Analysts’ Weekly Ratings Updates for Crescent Capital BDC (CCAP)

A number of firms have modified their ratings and price targets on shares of Crescent Capital BDC (NASDAQ: CCAP) recently:

• 5/18/2026 – Crescent Capital BDC was downgraded by Zacks Research from “hold” to “strong sell”.
• 5/16/2026 – Crescent Capital BDC was downgraded by Wall Street Zen from “hold” to “sell”.
• 5/15/2026 – Crescent Capital BDC had its “neutral” rating reaffirmed by B. Riley Financial, Inc..
• 5/15/2026 – Crescent Capital BDC had its price target lowered by Wells Fargo & Company from $13.00 to $12.00. They now have an “equal weight” rating on the stock.
• 5/15/2026 – Crescent Capital BDC was downgraded by Oppenheimer Holdings, Inc. from “outperform” to “market perform”. They now have a $16.00 price target on the stock, down from $19.00.
• 5/15/2026 – Crescent Capital BDC had its price target lowered by LADENBURG THALM/SH SH from $16.00 to $15.00. They now have a “buy” rating on the stock.
• 5/15/2026 – Crescent Capital BDC had its “market perform” rating reaffirmed by Oppenheimer Holdings, Inc.. They now have a $16.00 price target on the stock, down from $19.00.
• 5/14/2026 – Crescent Capital BDC was upgraded by B. Riley Financial, Inc. from “neutral” to “buy”. They now have a $13.50 price target on the stock.
• 4/16/2026 – Crescent Capital BDC had its price target lowered by Keefe, Bruyette & Woods from $15.50 to $15.00. They now have an “outperform” rating on the stock.

Crescent Capital BDC Dividend Announcement

The firm also recently declared a special dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Monday, November 30th. This represents a yield of 107.0%. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 409.76%.

Insider Buying and Selling at Crescent Capital BDC

In related news, President Henry Chung acquired 4,500 shares of the stock in a transaction on Thursday, May 21st. The stock was acquired at an average cost of $11.45 per share, for a total transaction of $51,525.00. Following the completion of the acquisition, the president directly owned 20,722 shares of the company’s stock, valued at approximately $237,266.90. This represents a 27.74% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jason Breaux purchased 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The shares were purchased at an average price of $11.19 per share, for a total transaction of $55,950.00. Following the completion of the transaction, the chief executive officer directly owned 52,636 shares of the company’s stock, valued at $588,996.84. This represents a 10.50% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 1.23% of the company’s stock.

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.